Ambrosia Is Launching “Real Time CGM With Activity, Direct To Watch” In 195 Countries.

Posted on
by

Ambrosia rt-CGM+ is now regarded as the most advanced, easy-to-use, and affordable real-time continuous glucose monitoring system worldwide for patients with diabetes, athletes, and people looking to lose weight.

In a ground-breaking development, Ambrosia is finally set to launch Ambrosia Real-time CGM with Activity in 195 countries. Ambrosia rt-CGM+ is currently the only real-time continuous glucose monitoring system that supports Apple Watch and all Android watches with Wear 2 OS and Android 8 operating systems and can be used without a phone.

The Ambrosia team has already contributed to lowering the cost of real-time CGM by 65% in North America and European countries and by more than 85% in several Asian countries through the use of their innovative technologies. In order to provide glucose readings in real-time to diabetes management, weight loss, and fitness companies and give comparable results for their customers, the company is now set to make its revolutionary technology available to the world’s other countries at affordable pricing.

Numerous individuals with diabetes observed a significant improvement in their A1c and Time-in-Range(TIR) post during the past few years, thanks to Ambrosia technology. Those using Ambrosia technology reported a 23% improvement in their A1c and a 47% improvement in TIR when compared to patients using alternative rt-CGMs. Even independent clinical research conducted by third-party businesses attested to the fact that their real-time CGM helps patients in lowering their A1c and raising Time-in-Range.

Ambrosia rt-CGM+ uses the LinkBluCon app for patients, FollowBluCon app for Caregivers, Ambrosia’s web platform ambrosia.care for providers, and NightRider BluCon to transmit glucose information from all types of Libre sensors(including Libre 2) over Bluetooth to SmartWatch and phone. As per reports, NightRider BluCon has already helped many people get access to real-time continuous glucose readings in more than 100 countries.

“Ambrosia is committed to making the world diabetes free. Till then, we will keep building best-in-class, easy-to-use, and affordable products to help patients and caregivers monitor their glucose. We will continue to innovate and make sure real-time continuous glucose monitoring is affordable for most people in the world,” stated Piyush Gupta, CEO of Ambrosia Systems.

Media Contact
Company Name: Ambrosia Systems Inc
Contact Person: Mia Flaherty
Email: Send Email
City: San Francisco
Country: United States
Website: https://www.ambrosiasys.com/